XTORO
Active substance: finafloxacin
SUSPENSION · FINAFLOXACIN 3 mg/mL
United StatesActive
Marketing holder: Fonseca Biosciences, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FINAFLOXACIN · 3 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-d9f9-7b96-bbed-fae6b04327c9;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 83709-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- AURICULAR (OTIC)
Sources
- product · openFDA NDC · 83709-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 83709-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 83709-001 · Verified 2026-10-09 · open in source